TNNI3 and familial dilated cardiomyopathy: We have employed the genetic modification of thin filament regulation to inform potential approaches to DCM therapy in which there is an increase in the myofilament Ca2+ response by expressing slow skeletal TnI (ssTnI) to alter the cTnC-cTnI interaction [98].